Frontiers in Neuroscience seminar: “From Protein Metabolism to Biomarkers and Prevention Trials”
Welcome to a lecture by our guest speaker Dr. Randall J. Bateman, Charles F. and Joanne Knight Distinguished Professor of Neurology at Washington University School of Medicine in St. Louis, US
“From Protein Metabolism to Biomarkers and Prevention Trials”
Dr. Bateman’s research focuses on the pathophysiology and development of improved diagnostics and treatments of Alzheimer’s disease (AD). His lab reported a highly accurate blood test for AD amyloid plaques, which launched into commercial production of the first blood test to help diagnose AD. They discovered that tau production is increased in AD and a novel form of an Alzheimer’s protein found in cerebrospinal fluid can indicate what stage of the disease a person is in. His research in DIAN has provided evidence for a cascade of events beginning decades before symptom onset that leads to AD dementia, supporting development of AD prevention trials. He is a productive innovator with 47 active/pending patents, and co-founder of C2N Diagnostics.
Host: Oskar Hansson